Day 3: Thursday, 16 November 2023
|
7.30am to 8.30am
|
Morning Session
|
Panithaya Chareonthaitawee
|
Challenging Cases in Cardiology
|
Session 7:
|
Radiotracer Therapies 2:
|
|
8.30am to 10.30am
|
Alpha therapies and New agents
|
Neeta Pandit Taskar
|
Patient selection for radiotracer therapies in metastatic prostate cancer/NET.
|
R Wahl
|
Radiopharmaceutical Therapies: Response Assessment.
|
Neeta Pandit Taskar
|
FAP-targeted radionuclide therapy in metastatic I-131 refractory Thyroid cancer
|
H Chen
|
10.50am to11.40am
|
Tea Break 10.30-10.50
|
All
|
Panel Discussion: Future of Hybrid Imaging
|
Session 8:
|
Pediatrics & General NM:
|
|
12.30pm to 2.20pm
|
Theranostics in pediatric patients- high dose 131I -MIBG therapy-
|
Neeta Pandit Taskar
|
General Pediatrics Nuclear Imaging
|
H Nadel
|
Molecular imaging for the Twilight years: Focus on Parkinsonism and Dementia
|
J Bomanji
|
Imaging in Neuroblastoma
|
H Nadel
|
Session 9
|
Recent Developments Session 2
|
|
2.40pm to 4.30pm
|
FAPI PET/CT: Initial Experience from KHCC and Jordan
|
Akram AlIbrahim
|
Molecular Imaging in Oncology: Novel PET radiopharmaceuticals beyond FDG
|
F Marafi
|
PEM: Clinical and research Applications
|
Dr. Haroon
|
Applications of PET/ MR in Pediatrics
|
H Nadel
|
2.20 to 2.40
|
Tea Break
|
|
4.30pm to 5.15pm
|
Concluding session, Awards and Votes of Thanks
|
|